GE Healthcare’s Whatman Non-Indicating FTA Mini Cards collect, stabilize, process, transport, and archive blood samples.
Whatman FTA technology consists of two distinct chemistries, both of which have the ability to lyse cells on contact, denature proteins, and protect DNA from degradation. FTA chemistry contains chemical denaturants and a free radical scavenger. With FTA, the DNA remains tightly bound while proteins and inhibitors are washed from the matrix. There are three options for DNA analysis with FTA cards: direct amplification, standard amplification with rinsing (“punch-in” method), and extraction of DNA from the card.
FTA cards are available as non-indicating cards for use with colored samples, such as blood.
|
- 自定义